INNOVATIVE THERAPIES BASED ON A NEXT-GENERATION DRUG DELIVERY PLATFORM

Business Development & Partnering

At MDimune, we are passionate about changing the world by developing innovative therapeutics.

Business Areas

01
Development of cancer therapeutics using immune cell-derived vesicles
  • Developing targeted drug delivery to cancer cells using vesicles loaded with cytotoxic agents : in vitro and in vivo analyses/preclinical studies for various anticancer drugs underway.
  • Developing autologous cancer therapeutics by administering anticancer drugs loaded in the vesicles that are derived from leukocytes isolated from cancer patients
  • Versatile technology to carry various molecular cargos (siRNAs/miRNAs, proteins/peptides, small molecules, etc.)
02
Development of therapeutics using stem cell-derived vesicles
  • Developing a platform technology using adult stem cell-derived vesicles exhibiting anti-inflammatory and regenerative properties to treat various diseases
  • Improving synergistic effects by combining regenerative potentials of adult stem cell-derived vesicles with known efficacies of various drugs loaded in the vesicles
  • Developing therapeutics to treat incurable diseases such as osteoarthritis, COPD, neurodegenerative diseases, etc
03
Manufacturing and supply of BioDrone® drug delivery system
  • Providing vesicles derived from immune cells or stem cells to pharmaceutical companies to promote the development of novel therapeutics
  • Providing customized services by producing vesicles from cell types of interest to facilitate the R&D efforts of pharmaceutical companies

Partnering

MDimune Inc. is partnering with world-renowned drug development experts to achieve global success.
  • Collaboration
    Building a professional network with universities, research institutes, and pharmaceutical companies
  • Global marketing
    Seeking marketing partners for the global application of technology and licensing
  • Clinical trial
    Building a clinical trials network with major hospitals in Korea